COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL LimitedRead Our Letter to Patients
Ironman Athlete Takes On Primary Immunodeficiency
The race has changed, but marathoner Stacy Ahearn is still pushing ahead following a rare disease diagnosis at age 40.
How to put your best (virtual) foot forward.
With more job interviews happening online because of COVID-19, CSL Behring’s Talent Acquisition team shares best practices fo…
The Fight Is In Us
With a mission to encourage plasma donations, a new campaign finds support from a COVID-19 survivor group, medical research c…
Dr. David Fajgenbaum Takes on COVID-19
University of Pennsylvania research team examines the “cytokine storm” in pursuit of effective treatments.
New Leader Takes Over at BIO
During a pandemic, the global biotech organization hires Dr. Michelle McMurry-Heath to tell the story of science.
1-Minute Video: A Potential COVID-19 Treatment
Learn how antibody-rich plasma is being developed into a “hyperimmune."
Are Video Calls Wearing You Out?
That just means you’re human, say experts in human behavior. Here are five ways to find balance and human connection as work …
Family Adopts a Son Who Has Hemophilia
Meet the Smith Family
A U.S. family opens their home, and hearts, to a new son who has hemophilia.